Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients

被引:30
作者
Shcherbak, NS
Shutskaya, ZV
Sheidina, AM
Larionova, VI
Schwartz, EI [1 ]
机构
[1] RAS, Lab Human Mol Genet, St Petersburg Phys Inst, St Petersburg 188350, Area Gatchina, Russia
[2] St Petersburg Pediat Med Acad, Dept Med Genet, St Petersburg 194100, Russia
[3] St Petersburg State Med Univ, Mol Cardiol Lab, St Petersburg 197189, Russia
关键词
methylenetetrahydrofolate reductase; C677T MTHFR mutation; insulin-dependent diabetes mellitus (IDDM); diabetic nephropathy;
D O I
10.1006/mgme.1999.2909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A missense mutation in the methylenetetrahydrofolate reductase gene (MTHFR), C677T, results in a thermolabile variant with reduced activity, Elevated levels of homocysteine have been recognized as a risk factor for vascular disease. Insulin-dependent diabetes mellitus (IDDM) is characterized by a higher prevalence of vascular complications. We analyzed the frequency of C67TT MTHFR in IDDM and control groups. The genotype distribution did not differ between control subjects (n = 297) and IDDM patients (n = 392) (chi(2) = 5.413, df = 2, P > 0.05). The MTHFR T677T genotype was found significantly more frequently in IDDM patients with diabetic nephropathy (0.216) compared with the IDDM patients without nephropathy (0.056); the odds ratio was 2.635 (95% CI 1.768-3.927). Thus, we suggest that the T677T genotype of the MTHFR gene is an independent risk factor for diabetic nephropathy in IDDM. (C) 1999 Academic Press.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 14 条
[1]  
Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818
[2]   Homocysteine mediated endothelial cell toxicity and its amelioration [J].
Blundell, G ;
Jones, BG ;
Rose, FA ;
Tudball, N .
ATHEROSCLEROSIS, 1996, 122 (02) :163-172
[3]   Genetic susceptibility to nephropathy in insulin-dependent diabetes: From epidemiology to molecular genetics [J].
Doria, A ;
Warram, JH ;
Krolewski, AS .
DIABETES-METABOLISM REVIEWS, 1995, 11 (04) :287-314
[4]   Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups [J].
Franco, RF ;
Araújo, AG ;
Guerreiro, JF ;
Elion, J ;
Zago, MA .
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) :119-121
[5]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[6]  
Guba SC, 1996, AM J CLIN PATHOL, V106, P709
[7]  
HA SK, 1997, KIDNEY INT S, V60, pS28
[8]   Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes [J].
Heesom, AE ;
Hibberd, ML ;
Millward, A ;
Demaine, AG .
DIABETES, 1997, 46 (02) :287-291
[9]   Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia [J].
Kang, SS ;
Wong, PWK .
ATHEROSCLEROSIS, 1996, 119 (02) :135-138
[10]   Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM [J].
Kimura, H ;
Suzuki, Y ;
Gejyo, F ;
Karasawa, R ;
Miyazaki, R ;
Suzuki, S ;
Arakawa, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :666-673